Welcome at the Erasmus MC Cancer Institute

Cancer can affect anyone

We are the Erasmus MC Cancer Institute. Every day, we are dedicated to helping patients with complex or rare forms of cancer. We offer people with cancer the best available and personalised care. Whether to treat the disease or to improve quality of life as much as possible.

We also conduct scientific research. We want to further improve care in oncology. We are constantly searching for new treatments and medicines to fight cancer. For our patients today and for future generations. Together, we are committed to a future without cancer.

Our story

Second opinion

Amazing Erasmus MC: Oncology

News

June 11, 2026
Nitika investigates why some cancer cells are resistant to chemotherapy

Nitika Taneja is working on a technique to better visualize the DNA of tumor cells. Through this work, she hopes to contribute to improved treatment options from the laboratory for people with cancer. ‘Sometimes half of the patients do not respond to a treatment.’
Read more
News

January 28, 2026
DNA test: who benefits from chemotherapy for ovarian cancer?

Why does chemotherapy work for some patients and not for others? Researchers at Erasmus MC have found a promising clue in the dividing DNA of cancer cells. They hope this will enable them to predict which women with ovarian cancer will truly benefit from chemotherapy.
Read more
News

November 13, 2025
World’s first database for advanced cutaneous squamous cell carcinoma

Researchers at the Erasmus MC Cancer Institute have developed a nationwide database containing a wealth of information on cutaneous squamous cell carcinoma (CSCC). This resource will soon enable doctors to provide more personalized treatments for patients with this type of skin cancer.
Read more
News

November 7, 2025
New mechanism in BRCA2 tumors discovered: why chemotherapy sometimes fails

Why do some BRCA2 tumors eventually stop responding to chemotherapy? Researchers at Erasmus MC discovered how these tumors are still able to repair their DNA damage and how they evade the effects of chemotherapy.
Read more
News

July 28, 2025
New Erasmus MC Subsidiary Develops Personalized Immunotherapy

Erasmus MC has established a new company dedicated to developing a new form of immunotherapy. This new therapy — a personalized cancer vaccine — is intended for patients with pancreatic cancer.
Read more
News

December 3, 2024
European grants for research into stomach cancer and motor control

Neuroscientist Zhenyu Gao and molecular geneticist Miao-Ping Chien from Erasmus MC have been awarded Consolidator Grants from the European Research Council. They will use this 2 million euro grant for research into difficult-to-treat stomach cancer and the brain’s control of movement.
Read more